Accelerating the Future...

News Page Banner Image

Katerva Awards 2019 - Nominee Candidate Form

The Katerva Award is the pinnacle of global sustainability recognition. Through Katerva, the best ideas on the planet are identified, refined and accelerated toward impact at a global level.


Katerva isn’t looking for ideas that will improve the world in small increments. We are looking for game-changers and industry breakers; ideas that leap efficiency, lifestyle, consumption and action a generation ahead of current thinking.

Single-digit percent change isn't enough.

We're looking for triple-digit and beyond.

This is where you can help.

We invite you to submit innovations and solutions that truly make a difference, such as Ethereum, The Ocean Cleanup, Nissan’s Leaf, Barefoot Power.

In our nominees we look for solutions that will:

• Have a certain positive environmental or social impact.
• Disrupt one or more market segments and / or social norms.
• Be highly differentiated.
• Be scientifically and technologically feasible.
• Be financially viable.
• Be or is ready to market.
• Scale for wider and lasting impact.

Thank you for your support!


Add a Nominee :
10 words left
Description of the Innovation :
25 words left
25 words left
25 words left
25 words left
150 words left

Should you be accepted to the Awards Program you will have an opportunity to provide additional links and upload documents.

Meet Dr. Reza Yavari and his Chronic Disease solution: Beyond Care, a digital self-coaching program for obesity and diabetes:

Q: What is the problem you’re trying to solve?
Prevention and management of diabetes and obesity worldwide.

Q: How are you trying to solve it?
Providing a scalable, affordable, and clinically validated digital coaching platform for lifestyle change aimed at diabetes and obesity.

Q: What is unique about your solution?
The solution is a novel, clinically tested, and validated mobile solution for end users worldwide.

Q: What’s the biggest challenge or barrier your solution faces?
Once clinically implemented at a large scale, the main challenge will be to adapt our approach to diverse populations with different cultures.

Q: Tell us a story! Who will your solution impact?
Tens of millions of people facing diabetes and/or battling obesity do not have access to healthcare providers and lack sufficient knowledge and other resources for self-coaching and lifestyle change. These individuals would include everyone from those living in rural areas of the United States, such as farmers, to people living in overpopulated cities in developing countries or even inner cities in the US, where there are many socioeconomic barriers to good medical care.

The source for our second example would prefer to remain anonymous, so we’ve changed their name and altered some key information.

Q: What is the problem you’re trying to solve?
Cancer is a worldwide problem. While numerous drugs are available, choosing the wrong ones loses valuable treatment time and ultimately results in poor outcomes.

Q: How are you trying to solve it?
ABC’s Bio Chips allow cancer centers to recreate an individual’s tumor in a couple of days to show which drugs will be the most effective. Oncologists can see in real-time drug uptake and tumor response and even visualize how aggressive (metastatic) the patient’s cancer is. This patented technology creates a realistic dynamic in vitro means of assessing drug behavior quickly, efficiently and accurately.

Q: What is unique about your solution?
ABC’s’ proprietary custom chips provide a more detailed understanding of real time drug behavior than has ever been available. This platform technology applies to drug development and more importantly is the key to personalized precision medicine.

Q: What’s the biggest challenge or barrier your solution faces?
Once clinically implemented at a large scale, the main challenge will be to adapt our approach to diverse populations with different cultures.

Q: Tell us a story! Who will your solution impact?
The need for effective drugs is increasing at a rapid rate and will continue to do so on a worldwide basis. Equally important is the fact that new drugs must be more effective and cost justifiable. As healthcare costs continue to rise, worldwide pharmaceutical companies will come under more cost pressures as reimbursements gravitate become outcomes based. In addition, there is a focus on true personalized medicine, as what was once a dream becomes reality. Although these dynamics exist, the drug development paradigm has not changed and pharma companies still rely on outdated time-consuming approaches (well plates, weak in-vivo models etc.) The ability to truly determine how a drug will behave in vivo well in advance of actual testing will accelerate development, identify the most effective candidates and create the path to true personalized medicine.

Your contact information:
Yes Don't mind No

Accelerating the Future...